GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Clinical trial NCT05216042 · RECRUITING

Trial details

NCT number: NCT05216042
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cardiovascular Diseases Natriuretic Peptides Cardiometabolic Diseases Energy Expenditure Glucose Metabolism Exercise Obesity

Start date: 2022-04-01
Primary completion: 2026-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.